MENUMENU
The notion of “time is money” was born in the factories of the Industrial Revolution. Since then, people have always strived towards greater efficiency, trying to achieve more in less time. As Artificial Intelligence (“AI”) and machine learning (“ML”) become more conventional, stakeholders to the global intellectual property (“IP”) system are gradually adopting these tools.…
Read more
There is no uncertainty that Artificial Intelligence is significantly affecting the field of drug discovery. The IP issues in this put forth a test, of sorts, for drug discovery. The improvement of a clinically developed drug for the most part costs a huge amount of money, so the compound should be secured by an overall…
Read more